Si-Bone (SIBN) Capital Expenditures (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 635.71% |
| Dec 31, 2025 | 76.89% |
| Sep 30, 2025 | 59.81% |
| Jun 30, 2025 | -150.92% |
| Mar 31, 2025 | 127.11% |
| Dec 31, 2024 | -210.16% |
| Sep 30, 2024 | 979.34% |
| Jun 30, 2024 | -137.90% |
| Mar 31, 2024 | 446.46% |
| Dec 31, 2023 | 107.37% |
| Sep 30, 2023 | -290.60% |
| Jun 30, 2023 | 5.23% |
| Mar 31, 2023 | 138.31% |
| Dec 31, 2022 | -288.47% |
| Sep 30, 2022 | 78.51% |
| Jun 30, 2022 | -12.01% |
| Mar 31, 2022 | 6,397.14% |
| Dec 31, 2021 | 100.94% |
| Sep 30, 2021 | -267.81% |
| Jun 30, 2021 | 12.10% |
| Mar 31, 2021 | 141.86% |
| Dec 31, 2020 | -48.91% |
| Sep 30, 2020 | 1,619.35% |
| Jun 30, 2020 | 78.85% |
| Mar 31, 2020 | -93.55% |
| Dec 31, 2019 | 8.04% |
| Sep 30, 2019 | -0.93% |
| Jun 30, 2019 | 437.86% |
| Mar 31, 2019 | -84.56% |
| Dec 31, 2018 | 1,562.90% |
| Sep 30, 2018 | 48.76% |
| Jun 30, 2018 | -155.50% |
| Mar 31, 2018 | 101.85% |